Baird Names Mereo BipPharma Group (MREO) a New Fresh Pick into Clinical Data
Tweet Send to a Friend
Baird analyst Jack Allen reiterated an Outperform rating and $8.00 price target on Mereo BipPharma Group (NASDAQ: MREO).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
